{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:50:52Z","timestamp":1791823852984,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jaclp.2023.12.002","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T23:32:51Z","timestamp":1703547171000},"page":"222-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2879-5258","authenticated-orcid":false,"given":"Jesus","family":"Ramirez-Bermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6382-2699","authenticated-orcid":false,"given":"Miguel","family":"Restrepo-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Espinola-Nadurille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4823-1556","authenticated-orcid":false,"given":"Victoria","family":"Martinez-Angeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Lopez-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Hernandez-Vanegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-217X","authenticated-orcid":false,"given":"Francisco","family":"Martinez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Ruiz-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Rivas-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Flores-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2023.12.002_bib1","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","volume":"138","author":"Warren","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jaclp.2023.12.002_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.jaclp.2023.12.002_bib4","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1017\/S0033291722001027","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study","volume":"53","author":"Espinola-Nadurille","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaclp.2023.12.002_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.psym.2017.02.014","article-title":"Autoimmune Encephalopathy for psychiatrists: when to suspect Autoimmunity and what to do next","volume":"58","author":"Oldham","year":"2017","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jaclp.2023.12.002_bib8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis","volume":"70","author":"Kayser","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib9","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1212\/NXI.0000000000000280","article-title":"Neuroleptic intolerance in patients with anti-NMDAR encephalitis","volume":"3","author":"Lejuste","year":"2016","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.jaclp.2023.12.002_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaclp.2023.12.002_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.jaclp.2023.12.002_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.neuropsych.18010005","article-title":"Anti- N -Methyl-D-Aspartate receptor encephalitis: a review of psychiatric phenotypes and management Considerations: a report of the American neuropsychiatric association committee on research","volume":"31","author":"Sarkis","year":"2019","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jaclp.2023.12.002_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0033291719003283","article-title":"Psychiatric management of anti-NMDAR encephalitis: a cohort analysis","volume":"51","author":"Warren","year":"2021","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaclp.2023.12.002_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1017\/neu.2019.46","article-title":"Characterisation and outcome of neuropsychiatric symptoms in patients with anti-NMDAR encephalitis","volume":"32","author":"Restrepo-Martinez","year":"2020","journal-title":"Acta Neuropsychiatr"},{"key":"10.1016\/j.jaclp.2023.12.002_bib16","first-page":"1","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study","volume":"53","author":"Espinola-Nadurille","year":"2022","journal-title":"Psychol Med"},{"key":"10.1016\/j.jaclp.2023.12.002_bib17","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jaclp.2023.12.002_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0025-7125(16)30278-4","article-title":"Neuroleptic malignant syndrome","volume":"77","author":"Caroff","year":"1993","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaclp.2023.12.002_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaclp.2023.12.002_bib20","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/NDT.S195706","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis mimics neuroleptic malignant syndrome: case report and literature review","volume":"15","author":"Wang","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jaclp.2023.12.002_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/19418744211002978","article-title":"Neuroleptic malignant syndrome in a patient with anti-N-Methyl-D-Aspartate receptor encephalitis: case report and review of related literature","volume":"12","author":"Sarmiento","year":"2022","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jaclp.2023.12.002_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2016.08.002","article-title":"Frequent rhabdomyolysis in anti-NMDA receptor encephalitis","volume":"298","author":"Lim","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/brainsci12091130","article-title":"Autoimmune encephalitis: a Physician\u2019s Guide to the clinical Spectrum diagnosis and management","volume":"12","author":"Patel","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.jaclp.2023.12.002_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/02698811231158232","article-title":"Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for psychopharmacology","volume":"37","author":"Rogers","year":"2023","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCP.0b013e3181c9bfe6","article-title":"Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome","volume":"30","author":"Lee","year":"2010","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2023.12.002_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0006-3223(85)90060-5","article-title":"Neuroleptic catatonia and its relationship to psychogenic catatonia","volume":"20","author":"Fricchione","year":"1985","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaclp.2023.12.002_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-444-64196-0.00012-1","article-title":"Beach S: Cingulate-basal ganglia-thalamo-cortical aspects of catatonia and implications for treatment","volume":"166","author":"Fricchione","year":"2019","journal-title":"Handb Clin Neurol"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296023008534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296023008534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T21:08:29Z","timestamp":1729199309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296023008534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2667296023008534"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2023.12.002","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2023.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}